Study links thymus radiation to worse lung cancer outcomes - News-Medical
Study links thymus radiation to worse lung cancer outcomes News-Medical
Онкология
🎗️Лента новостей
🎗️
Онкология
Pershing Square Sohn Cancer Research Alliance Cancer Prize 2027 - Oncodaily
Pershing Square Sohn Cancer Research Alliance Cancer Prize 2027 Oncodaily
Онкология
Thymus radiation is linked to worse outcomes in patients with non-small cell lung cancer
Until recently, the thymus was thought to be of little use beyond puberty, but new research has shown that radiation to the organ is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC).
Онкология
Story-based testing reveals undetected 'chemobrain' memory issues
Standard memory tests, such as word-pair or list-learning tests used in clinics, may fail to detect the real-life memory problems reported by many female breast cancer survivors after chemotherapy. A new study in journal Translational Neuroscience, "Limitations of Standard Memory Assessments in Breast Cancer…
Онкология
An alternative to bone marrow sampling: Children with sarcomas may be spared a painful procedure
Rhabdomyosarcomas are a rare form of cancer; however, the disease is responsible for about 60% of all soft-tissue sarcomas in children. Rhabdomyosarcomas are aberrant, malignant forms of muscle tissue. Early detection of bone marrow infiltration by tumor cells is crucial when planning treatment.
Онкология
Blocking cellular 'freecycling' may slow bone marrow scarring in myelofibrosis
In a new study published in Nature Communications, Boston Children's Hospital researchers identified a new target responsible for scar formation in the bone marrow of patients with a type of blood cancer known as myelofibrosis. Combining traditional myelofibrosis therapy with drugs that block scar formation may be a…
Онкология
New oral nanomedicine boosts effectiveness of cancer immunotherapies
Immune checkpoint blockade is a form of cancer treatment that works by releasing the natural brakes on the immune system, allowing T cells to find and destroy cancer cells. Although it has transformed cancer immunotherapy, patients usually have low response rates. In a new study published in Nature Nanotechnology…
Онкология
First-in-human pilot trial improves stem cell collection and delivery for sickle cell gene therapy
Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from Boston Children's Hospital have helped smooth the road to gene therapy with a new approach that collects enough of the…
Онкология
Acute myeloid leukemia increasingly impacting older adults globally
Acute myeloid leukemia (AML) poses an increasing global burden for older adults, according to a study published online Aug. 19 in the Journal of Geriatric Oncology.
Онкология
New mRNA immunotherapy eliminates pancreatic tumors in mice
Inspired by the work of the RNA Therapeutics Institute at UMass Chan Medical School and the development of the COVID vaccine, Marcus Ruscetti, Ph.D., and Chaitanya Naimesh Parikh, Ph.D. '26, have developed an immunotherapy using a cocktail of messenger RNAs (mRNA) that could potentially transform pancreatic cancer…
Онкология
Онкологи нашли способ уничтожить метастазы рака костей у детей - hightech.fm
Онкологи нашли способ уничтожить метастазы рака костей у детей hightech.fm
Онкология
Ziihera-Tevimbra combo grabs FDA nod in gastroesophageal cancers
The FDA approved two zanidatamab-hrii-based regimens as first-line treatment for adults with unresectable locally advanced or metastatic HER2-positive gastroesophageal adenocarcinoma. Zanidatamab-hrii (Ziihera, Jazz Pharmaceuticals) received approval in combination with fluoropyrimidine- and platinum-containing…